Faraz Ali

Chief Executive Officer

Professional Overview
Faraz Ali is an accomplished biotech executive with extensive experience in leading innovative gene therapy and regenerative medicine companies. As the Chief Executive Officer of Tenaya Therapeutics, he spearheads the development of novel therapies to address unmet medical needs. With a proven track record of driving strategic growth and fostering successful collaborations, Faraz is recognized for his expertise in the commercialization of cutting-edge treatments and his commitment to advancing the field of regenerative medicine.

Experience Summary

Current Role
As the Chief Executive Officer of Tenaya Therapeutics, Faraz Ali is responsible for setting the strategic vision and leading the company's efforts to develop transformative gene therapy and cell-based treatments. Under his guidance, Tenaya has made significant strides in its pipeline, with multiple programs advancing through clinical development. Faraz's exceptional leadership and industry knowledge have been instrumental in securing strategic partnerships and securing funding to fuel the company's growth.

Career Progression
Prior to his role at Tenaya Therapeutics, Faraz held senior leadership positions at prominent biotech companies, including REGENXBIO Inc., bluebird bio, and Sanofi Genzyme. As the Chief Business Officer at REGENXBIO, he played a pivotal role in the company's success, contributing to the advancement of its gene therapy pipeline and establishing valuable partnerships. At bluebird bio, Faraz served as the Vice President of Global Commercial Development and External Affairs, where he spearheaded the commercialization strategy for the company's innovative gene therapies. His experience in the rare disease space, particularly at Sanofi Genzyme, has also been instrumental in shaping his understanding of the unique challenges and opportunities in the field of regenerative medicine.

Academic Background
Faraz Ali holds a Bachelor of Science degree from the Massachusetts Institute of Technology, where he specialized in biomedical engineering. His strong academic foundation and technical expertise have been integral to his success in the industry.

Areas of Expertise

• Gene therapy and cell-based treatment development

• Commercialization and market access strategies

• Strategic alliance and partnership management

• Regulatory and clinical trial execution

• Rare disease and orphan drug development

• Organizational leadership and team-building

Professional Impact
Throughout his career, Faraz Ali has been a driving force in the advancement of regenerative medicine. He has played a pivotal role in the successful development and commercialization of several gene therapy and cell-based treatments, with a focus on addressing unmet medical needs. As a member of the Board of Directors at the Alliance for Regenerative Medicine, Faraz contributes to shaping the industry's regulatory and financing landscape, driving progress and innovation in the field.

Conclusion
With his extensive experience, strategic vision, and commitment to advancing the field of regenerative medicine, Faraz Ali is poised to continue leading Tenaya Therapeutics to new heights. His expertise in driving the commercialization of innovative therapies, coupled with his industry leadership and collaborative approach, make him a valuable asset in the biotech sector.